Clinical trial
Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From…
NCT00249444 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00249444 |
|---|---|
| Title | Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression |
| Official title | A Placebo Controlled Trial of Mirtazapine for Patients With Depression and Cocaine Dependence |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Dependence, Depression |
| Intervention type | Drug |
| Interventions | Mirtazapine, Placebo |
| Enrollment | 86 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Nov 7, 2005 |
| Last update posted | Oct 25, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: